AbbVie Inc. and Allergan PLC announced Tuesday that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to selling some properties if they commence a planned merger.
Trending:
AbbVie, Allergen sign deal with FTC to preserve merger plans